No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Momentum Reigned 2024: Buy-rated U.S. Stocks With the Highest RSI
Private Equity Firms Invested in Champions Oncology, Inc. (NASDAQ:CSBR) up 19% Last Week, Insiders Too Were Rewarded
Top Premarket Decliners
Champions Oncology | 10-Q: Q2 2025 Earnings Report
Champions Oncology Analyst Ratings
Express News | Champions Oncology Inc : Craig-Hallum Raises Target Price to $8 From $6